Related Experiment Video
Updated: Sep 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes
Joseph Lotem1, Hilah Gal, Rachel Kama
1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Abstract:
Using DNA microarray and clustering of expressed genes we have analyzed the mechanism of inhibition of wild-type p53-induced apoptosis by the cytokine interleukin 6 (IL-6) and the calcium mobilizer thapsigargin (TG). Clustering analysis of 1,786 genes, the expression level of which changed after activation of wild-type p53 in the absence or presence of IL-6 or TG, showed that these compounds did not cause a general inhibition of the ability of p53 to up-regulate or down-regulate gene expression. Expression of various p53 targets implicated as mediators of p53-induced apoptosis was also not affected by IL-6 or TG. These compounds thus can bypass the effect of wild-type p53 on gene expression and inhibit apoptosis. IL-6 and TG activated different p53-independent pathways of gene expression that include up-regulation of antiapoptotic genes. IL-6 and TG also activated different differentiation-associated genes. The ability of compounds such as cytokines and calcium mobilizers to inhibit p53-mediated apoptosis without generally inhibiting gene expression regulated by p53 can facilitate tumor development and tumor resistance to radiation and chemotherapy in cells that retain wild-type p53.
Insights
Interleukin 6 (IL-6) and thapsigargin (TG) inhibit p53-induced apoptosis without broadly affecting p53 gene regulation. These compounds promote tumor development and resistance to cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Wild-type p53 is a tumor suppressor protein that induces apoptosis (programmed cell death).
- Interleukin 6 (IL-6) and thapsigargin (TG) are known to inhibit p53-mediated apoptosis.
- The precise mechanism by which IL-6 and TG inhibit p53-induced apoptosis remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which IL-6 and TG inhibit wild-type p53-induced apoptosis.
- To determine if IL-6 and TG broadly affect p53's transcriptional regulatory functions.
- To identify alternative gene expression pathways activated by IL-6 and TG.
Main Methods:
- DNA microarray analysis was employed to examine gene expression profiles.
- Clustering analysis was performed on 1,786 genes showing altered expression after p53 activation.
- Gene expression was analyzed in the presence and absence of IL-6 or TG.
Main Results:
- IL-6 and TG did not broadly inhibit the ability of wild-type p53 to up-regulate or down-regulate gene expression.
- The expression of known p53 target genes involved in apoptosis was unaffected by IL-6 and TG.
- IL-6 and TG activated distinct p53-independent gene expression pathways, including antiapoptotic and differentiation-associated genes.
Conclusions:
- IL-6 and TG inhibit p53-mediated apoptosis by bypassing p53's transcriptional control.
- These compounds activate alternative signaling pathways that promote cell survival and differentiation.
- The ability of IL-6 and TG to inhibit apoptosis without affecting p53 gene regulation may contribute to tumor development and resistance to therapy.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

